BHADRA PHARMA CARE
O u r ph a r m a c e u t i c a l m a n u f a c t u r i n g pla n t is eq u i p p e d wit h m o d e r n hig h- sp e e d m a c h i n e s an d inte g r a t e d pa c k a g i n g line s to be co s t effi ci e n t. Ext e n s i v e us e of vis u a l ins p e c t i o n m a c h i n e s , m u l ti- stati o n ta bl e t pr e s s e s , attr a c t i v e pri m a r y pa c k i n g , liq ui d m a n u f a c t u r i n g an d fillin g line s are so m e of th e ex a m p l e s . T h e pla n t wit h hig h ca p a c i t i e s an d sc o p e for fut u r e ex p a n s i o n is ca p a b l e of m a n u f a c t u r i n g all ph a r m a c e u t i c a l do s a g e (Al o p a t h i c as w e ll as Ay u r v e d i c) for m s viz. tabl e t s, ca p s u l e s , or al liq ui d, ext e r n a l liq ui d, dr y syr u p, oint m e n t s , cre a m , lotio n s , gel s, etc. Anti Depressants: Sr. NO Molecules Dosage Forms Strength Anti - Convulsants : Sr. NO Molecules Dosage Forms Strength
P h e n o b a r b i t o n e & A m y l o b a r b i t o n e
P h e n o b a r b i t o n e & A m y l o b a r b i t o n e S yr u p
1 0 0 m g + P h e n o b a r b i t o n e 30 m g
Anti – Asthamatics: Sr. NO Molecules Dosage Forms Strength Antacids: Sr. NO Molecules Dosage Forms Strength
Al 400 m g + M g H y d r o x i d e 400 m g
(Al 200 m g + M g 200 m g)/5 ml - 1 5 0 m l
Diuretics: Sr. NO Molecules Dosage Forms Strength Erectile Dysfunction: Sr. NO Molecules Dosage Forms Strength Drugs Acting on Urethra & Vagina: Sr. NO Molecules Dosage Forms Strength
6's, 1 5 g G el 1 % (Eac h), 30 g G e l 2 % w/w tu b e
Topical Infectives: Sr. N O M o l e c u l e s Anti - Diabetics & Hyperglycaemics: Sr. NO Molecules Dosage Forms Strength
80 m g + R o s i g l i t a z o n e 2 m g
400 m g + Gli b e n c l a m i d e 2.5 m g ,500 m g + Gli b e n c l a m i d e 5 m g,400 m g + Gli p i z i d e 2.5 m g , 500 m g+ Gli p i z i d e 5 m g , 500 m g +Gli cl a z i d e 80 m g , 10 0 0 m g +Gli m e p r i d e 2 m g Ta b l e t s m , 5 0 0 m g+ R o s i g l it a z o n e 2 m g Ta b l e t s
Anaesthetics: Sr. N O M o l e c u l e s Other Drugs: Sr. N O M o l e c u l e s Anti - Psychotics & Antmanics: Sr. N O M o l e c u l e s Anti - Hypertensive Drugs: Sr. N O M o l e c u l e s
Lisi n o p r i l 5 m g , 2.5 m g + Lo s a r t a nP ot a s s i u m 25 m g
Urinary Anti – Infectives: Sr. N O M o l e c u l e s
Di s o d i u m H y d r o g e n Citr a t e
0.62 5 g + D i p o t H y d r o g e n Cit. 0.62 5 g/5 m l - 10 0 m l
Anti -Ulcer & Anti - Secretory Drugs: Sr. N O M o l e c u l e s
1 g m / 5 ml - 10 0 m l , 1 g m / 5 ml - 200 m l
Lo p e r a m i d e + Fur a z o l i d o n e
M e t r o n i d a z o l e 1 0 0 m g + N a l i d i x i c Aci d
M e t r o n i d a z o l e 200 m g + N o r fl o x a c i n
M e t r o n i d a z o l e 10 0 m g + N o r fl o x a c i n
M e t r o n i d a z o l e 10 0 m g + N o r fl o x a c i n
Ti ni d a z o l e 600 m g + C i p r o f l o x a c i n
Ti ni d a z o l e 600 m g + O f l o x a c i n
M e t r o n i d a z o l e 10 0 m g + O f l o x a c i n
Or n i d a z o l e 500 m g + O f l o x a c i n
(Withania Somnifera)Reference : Ayurbhisek
Care Medicated Skin Guard OintmentBadam Oil
Care Vesoline(For external use only)COMPOSITION :Badam Tel
Demotax OintmentCOMPOSITION :Tankan Amla 10% AB Salicylic Acid 10% RTS Part I Kapoor Baras 1% AB Parrafin Base Q.S.
Enzo effervescent GranulesCOMPOSITION :Jambiramla 45% AB 342 Sverjika 54% AB 624 Flavoured Excipients Q.S.
Vapo-Care Medicated Vaporising Rubbing Ointment
L’épidémiologie et les facteurs de risque chez les enfants atteints du trouble déficitaire d’attention avec ou sans hyperactivité : résultats préliminaires 1 1. Cameron Montgomery , Ph.D. Faculté d'éducation-Faculty of Education Université d'Ottawa-University of Ottawa 145, rue Jean-Jacques-Lussier-145 Jean-Jacques Lussier St. site web/web site : http://aix1.uottawa.ca/~
COMMENT A CONSTITUTIONAL RIGHT TO SUE MANAGED CARE ORGANIZATIONS illions of Americans rely on Managed Care Organizations M(“ MCOs”) for their health insurance, and every day MCOs make administrative decisions that deny necessary medical treatment to those in need.1 In the case of “wrongful” withholding of treatment, Americans would normally turn to the courts for help, but